KAREN DRENNER: Open Payments
NPI 1548872641 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 31 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 15 | $158 |
| Phathom Pharmaceuticals, Inc. | 2 | $148 |
| Janssen Biotech, Inc. | 3 | $82 |
| Boston Scientific Corporation | 1 | $64 |
| Ardelyx, Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| GENZYME CORPORATION | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: VOQUEZNA, ZENPEP, TREMFYA, SpyGlass, IBSRELA, DUPIXENT, VOWST, ENTYVIO.
Industry payments across AZ — which companies pay providers there.
